Nasdaq nltx.

SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design ...SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ...Based on analysts offering 12 month price targets for NLTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . The recent 15% drop in Neoleukin Therapeutics, Inc.'s (NASDAQ:NLTX) stock could come as a blow to insiders who purchased US$1.4m worth of stock at an average buy price of US$7.04 over the past 12 ...

Find the latest Institutional Holdings data for Neoleukin Therapeutics, Inc. Common Stock (NLTX) at Nasdaq.com.

SEATTLE, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that on January 7, 2021, it received a clinical hold letter from the U.S. Food and Drug Administration (FDA) related …The following insider purchased NLTX shares in the last 24 months: Bros. Advisors Lp Baker ($1,305,132.60). How much insider buying is happening at Neoleukin Therapeutics? Insiders have purchased a total of 411,148 NLTX shares in the last 24 months for a total of $1,305,132.60 bought.

The big shareholder groups in Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership.May 16, 2022 · Follow. SEATTLE, May 16, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design ... Based on analysts offering 12 month price targets for NLTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 817 ...(NASDAQ -AMNB) · Sculptor Capital Management Inc. (NYSE – SCU) · Neoleukin Therapeutics, Inc. (Nasdaq – NLTX) · Pardes Bioscience, Inc. (Nasdaq – PRDS).

Summary. Neoleukin Therapeutics (NASDAQ:NLTX) is a platform biotechnology company using the power of de novo protein design and computational biology for drug development.The company’s ...

SEATTLE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer, will participate in a fireside chat at …

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) is the most popular stock in this table. On the other hand Guaranty Federal Bancshares, Inc. (NASDAQ: GFED ) is the least popular one with only 2 bullish ...SEATTLE, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ...Nasdaq | NLTX U.S.: Nasdaq Neoleukin Therapeutics Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 1:34 p.m. EST Delayed quote $ 3.2200 -0.32 -9.04% After...View the option profit and loss chart for a NLTX short put option strategy ... NASDAQ. ` No trades. Upcoming Earnings. EPS. Market Cap. Div Yield.16 Agu 2023 ... ... ：2023-11-27 18:11 - ネオロイキン・セラピューティクス(NLTX) ... NASDAQ. ネオロイキン・セラピューティクス. $3.49. -0.05(-1.41 ...SEATTLE, April 16, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de ...Back to NLTX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...

Neoleukin Therapeutics Inc (NLTX) shares closed 3.3% lower than its previous 52 week low, giving the company a market cap of $181M. The stock is currently down 11.4% year-to-date, down 71.6% over ...Find the latest Insider Activity data for Neoleukin Therapeutics, Inc. Common Stock (NLTX) at Nasdaq.com.SEATTLE, June 01, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the appointment of Erin Lavelle to the company’s Board of Directors. Ms. Lavelle has more …Webull offers NLTX Ent Holdg (NLTX) historical stock prices, in-depth market analysis, NASDAQ: NLTX real-time stock quote data, in-depth charts, free NLTX options chain …Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) is the most popular stock in this table. On the other hand Guaranty Federal Bancshares, Inc. (NASDAQ: GFED ) is the least popular one with only 2 bullish ...Back to NLTX Overview. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...Neoleukin Therapeutics, Inc. Common Stock (NLTX) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.

Neoleukin Therapeutics Inc (NASDAQ:NLTX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.SEATTLE, March 12, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design ...

SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that... Neoleukin Therapeutics Announces 1 ...BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes ...Proposed merger to create Nasdaq-listed biotech company focused on advancing Neurogene’s differentiated portfolio of genetic medicines for complex... July 18, 2023 06:30 ET | Source: Neoleukin ...Sep 26, 2023 · Neoleukin Therapeutics (NASDAQ: NLTX) stock should have risen 500%. NLTX actually rose 7%. This is, of course, playing games with the difference between nominal and real prices. But those are games we should play because the difference between the two sets of prices is absolutely vital. Nasdaq | NLTX U.S.: Nasdaq Neoleukin Therapeutics Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 1:34 p.m. EST Delayed quote $ …Home NLTX • NASDAQ Neoleukin Therapeutics Inc Follow Share $3.54 After Hours: $3.22 (9.04%) -0.32 Closed: Nov 24, 1:34:21 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Spruce Power...

Follow. BALA CYNWYD, Pa., July 18, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact ...

SEATTLE, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ...

Jul 18, 2023 · Follow. BALA CYNWYD, Pa., July 18, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact ... SEATTLE, May 16, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ...NASDAQ:NLTX Neoleukin Therapeutics (NLTX) Stock Price, News & Analysis $3.47 +0.23 (+7.10%) (As of 11/22/2023 ET) Compare Share Today's Range …Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ETCompany Participants. Julie Rathbun - Investor Relations. Jonathan Drachman - Chief Executive ...Neoleukin Therapeutics, Inc. (Nasdaq: NLTX), relating to its proposed merger with Neurogene Inc. Under the terms of the agreement, NLTX shareholders are expected to own approximately 16% of the ...SEATTLE, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ...Neoleukin Therapeutics (NASDAQ:NLTX) shares rose 13.25% to $0.82. This security traded at a volume of 174.4K shares come close, making up 67.1% of its average volume over the last 100 days. The company’s market cap stands at $36.0 million.See the latest Neoleukin Therapeutics Inc stock price (NLTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Neoleukin Therapeutics, Inc. (Nasdaq: NLTX), relating to its proposed merger with Neurogene Inc. Under the terms of the agreement, NLTX shareholders are expected to own approximately 16% of the ...See the latest Neoleukin Therapeutics Inc stock price (NLTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Find the latest press releases from Neoleukin Therapeutics, Inc. Common Stock (NLTX) at Nasdaq.com.

Nov 30, 2023 · NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders. NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) and Neurogene Inc. is fair to Neoleukin sha... About Nasdaq Global Indexes Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and ...NLTX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / Instagram:https://instagram. xai stock symboltsla dividendseasy forex trading platformsimulated stock market game Find the latest Revenue & EPS data for Neoleukin Therapeutics, Inc. Common Stock (NLTX) at Nasdaq.com. best dental plans in coloradospne SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo ... zurp credit card Neoleukin Therapeutics (NASDAQ: NLTX) is owned by 196.32% institutional shareholders, 181.73% Neoleukin Therapeutics insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Neoleukin Therapeutics shareholder, owning 3.87M shares representing 43.92% of the company.Viewing insider transactions for Neoleukin Therapeutics, Inc.'s (NASDAQ:NLTX ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by ... Viewing insider transactions for Neoleukin Therapeutics, Inc.'s (NASDAQ:NLTX ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by ...